Clinical trial
Genetics of Hypertension Associated Treatments (GenHAT)
NCT00006294 · Donna Arnett, 257-5678, Other · Completed
Key facts
| NCT number | NCT00006294 |
|---|---|
| Title | Genetics of Hypertension Associated Treatments (GenHAT) |
| Official title | Pharmacological Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Anti-hypertensive Treatment |
| Acronym | GenHAT |
| Lead sponsor | Donna Arnett, 257-5678, Other |
| Collaborators | University of Minnesota National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases, Heart Diseases, Hypertension, Coronary Disease, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Chlorthalidone, Lisinopril, Amlodipine, Doxazosin |
| Enrollment | 37,939 |
| Start date | Sep 1, 1999 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 26, 2000 |
| Last update posted | Apr 26, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: